What is the translation of " 血癌 " in English?

• blood cancer
• blood cancers

Examples of using 血癌 in Chinese and their translations into English

组织成员和我们一样都是治疗血癌的医生。
We are like doctors with a cure to cancer.

正如我告诉过你们的，首先就是血癌。
As I have told you, first is the blood cancer.

而一旦发生感染，对于血癌患者来说可能是致命的。
An infection can be deadly for a cancer patient.

组织成员和我们一样都是治疗血癌的医生。
Members were doctors like us who treated blood cancers.

武田在血癌和出血障碍独特专长.
Takeda 's Unique Expertise in Blood Cancers and Bleeding Disorders.

在随访期内，有681人患上了血癌。
During the follow-up period, 681 people developed a blood cancer.

魔法”血液检验可能让血癌骨髓移植更安全.
Magic' blood test could make bone marrow transplants for blood cancer safer.

治疗已经显示最近承诺在打击血癌，如白血病。
The treatment has shown recent promise in fighting blood cancers such as leukemia.

干细胞死亡之前，他们有机会转化为血癌。
The stem cells die before they have an opportunity to transform into a blood cancer.

今年，估计加拿大有7,450人死于血癌。
This year, an estimated 7,450 people in Canada are expected to die of a blood cancer.

其它免疫治疗试验为患有一系列实体瘤和血癌的患者带来了新的治疗选择。
Other immunotherapy trials brought new treatment options to patients with a range of solid tumor and blood cancers.

诺华公司也在评估Kymriah对于患有b细胞淋巴瘤和其他血癌的成人。
Novartis is also evaluating Kymriah for adults with B-cell lymphoma and other blood cancers.

CART细胞疗法已经被批准用于治疗白血病和淋巴瘤--两种其他类型的血癌。
CAR T cell therapy has been approved for the treatment of leukemias and lymphomas- two other types of blood cancer.

与此同时，其他研究表明，酸牛奶是对抗结肠癌和血癌以及有益的（5，6）。
Meanwhile, other studies show that kefir could be beneficial against colon and blood cancer as well(5, 6).

他带她去田纳西大学兽医学院，在那里确定她有血癌。
He ended up taking her to the University of Tennessee College of Veterinary Medicine, where it was determined she had blood cancer.

这项研究的成果卡非佐米（carfilzomib，也叫Kyprolis），现已被用于治疗血癌多发性骨髓瘤。
The result of that work, carfilzomib(Kyprolis), is now used to treat the blood cancer multiple myeloma.

这种类型的血癌特别具有侵略性，并且造成高达25％的急性淋巴细胞性白血病。
This type of blood cancer is particularly aggressive, and it is responsible for up to 25 percent of acute lymphoblastic leukemias.

就在三年前，被诊断出套细胞淋巴瘤――一种罕见的血癌――基本上等于收到了死刑判决书。
Just three years ago, a diagnosis of mantle cell lymphoma- a rare type of blood cancer- was essentially a death sentence.

该团队现在正在使用他们的实验室模型来测试MCL-1抑制剂是否对其他类型的血癌有效。
The team is now using their laboratory model to test whether MCL-1 inhibitors are effective for other types of blood cancers.

这些药物可以阻止血癌细胞的生长，并且通常单独使用或更常用于组合治疗。
These drugs can arrest the growth of blood cancer cells and are usually employed either alone or most often in combination treatments.

目前，Gazyva在美国已经有三种获批的适应症，包括两种常见类型的血癌。
With this approval, Gazyva is available in the United States for three different indications across two common types of blood cancer.

我们的每一分钱都有助于我们击败血癌，改善所有受影响者的生活，阻止人们死亡.
Every penny raised helps us in our mission to beat blood cancer, improve the lives of all those affected, and stop people from dying.

这些人患其他癌症的可能性也超过三倍，包括结肠癌，黑色素瘤和血癌。
These people also were over three times more likely to have developed other cancers, including colon, melanoma and blood cancers.

然后患者接受更高强度的化疗方案，旨在杀死所有血癌细胞，但同时也杀死骨髓细胞。
The patient then receives a more intensive chemotherapy regimen that aims to kill all blood cancer cells but it also kill normal BM cells.

新研究显示维生素C如何阻止白血病干细胞的繁殖，从而阻止某些形式的血癌进展。
New research shows how vitamin C might stop leukemic stem cells from multiplying, and thus block some forms of blood cancer from advancing.

为了有效帮助患有血癌、自身免疫性疾病和神经障碍的患者，我们还积极探索新型的非药物治疗方法。
In our desire to positively impact patients with blood cancers, autoimmune diseases and neurological disorders, we also seek novel nonpharmacological approaches to treat these conditions.

进一步的测试使科学家能够确定干扰YTHDF2功能的生物途径，通过这种途径可以选择性地杀死血癌细胞。
Further trials enabled scientists to determine the biological pathway by which interfering with the function of YTHDF2 selectively kills blood cancer cells.

这些细胞编辑抗癌疗法虽然自身有严重的毒性问题，但在临床治疗数例难治血癌方面取得了前所未有的效果。
These modified cell-based cancer therapies, while suffering from their own serious toxicity issues, have produced unprecedented responses in several hard-to-treat blood cancers in the clinic.

进一步的测试使科学家能够确定干扰YTHDF2功能的生物途径，通过这种途径可以选择性地杀死血癌细胞。
Further testing enabled the researchers to determine the biological pathway by which interfering with the function of YTHDF2 selectively kills the blood cancer cells.